Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
36 participants
OBSERVATIONAL
2023-09-05
2024-03-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary objective of this study is to investigate the construct validity of ultrasound in diaphragm paralysis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diaphragm Ultrasound in Neuromuscular Disorders
NCT04045158
Ultrafast Ultrasound for the Functional Assessment of the Diaphragm
NCT05265351
Replaceability of Fluoroscopy and Ultrasound in the Evaluation of Hemidiaphragm Excursion
NCT04098939
Diaphragmatic Motion Using Linear Ultrasound
NCT03225508
Longitudinal Study on Diaframmatic Ultrasound in FSHD Patients
NCT06078852
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Construct validity The primary objective of this study is to investigate the construct validity of ultrasound in diaphragm paralysis. Validity is defined as the degree to which an instrument truly measure the construct(s) it purports to measure. In general, three different types of validity can be distinguished: content validity, criterion validity, and construct validity. Since evaluation with gold standard testing is invasive, as explained in the introduction, criterion validity testing not a feasible option. Therefore, in this study, we use construct validity to provide evidence of validity. Construct validity is defined as the degree to which the scores of an instrument (here: ultrasound) are consistent with scores of other instruments (here: pulmonary function tests, fluoroscopy). Construct validation is often considered less powerful, however, with strong theories and specific and challenging hypothesis, it is possible to acquire substantial evidence. Therefore, specific definitions of 'diaphragm paresis' and 'diaphragm paralysis' regarding diagnostic modalities are established in this protocol before the start of the study
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients suspected of diaphragm dysfunction
After inclusion, participants will be evaluated for diaphragm dysfunction with fluoroscopy, as in standard of care. Additionally, during the same hospital visit ultrasound will be performed.
The sonographer and the radiologist assessing the ultrasound and fluoroscopy, respectively, will be blinded to each other's' test results. Further assessment, and possible treatment, for diaphragm dysfunction is performed at the discretion of the treating physician.
The primary outcome is the concordance of diaphragm paralysis as determined by ultrasound compared with the construct for diaphragm paralysis based on traditional measurements.
ultrasound of the diaphragm
Parameters measured during ultrasound:
Thickening fraction; End-expiratory thickness, and; Diaphragm excursion.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrasound of the diaphragm
Parameters measured during ultrasound:
Thickening fraction; End-expiratory thickness, and; Diaphragm excursion.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Suspicion of diaphragm dysfunction based on medical history and/or physical examination; as determined by the treating physician.
Exclusion Criteria
* Inability for diaphragm imaging (e.g. mechanical ventilation, or unable to follow vocal instructions).
* Those not able or unwilling to give written informed consent.
* Pregnant women
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Isala
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wytze de Boer
M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
wytze de Boer, M.D.
Role: STUDY_DIRECTOR
Isala
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Isala Klinieken
Zwolle, Overijssel, Netherlands
UCMG
Groningen, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
de Boer WS, Parlevliet KL, Kooistra LA, Koster D, Nieuwenhuis JA, Edens MA, van den Berg JWK, Boomsma MF, Stigt JA, Slebos DJ, Duiverman ML. Ultrasound as diagnostic tool in diaphragm dysfunction: a prospective construct validity study. Respir Med. 2025 May;241:108083. doi: 10.1016/j.rmed.2025.108083. Epub 2025 Apr 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Diaphragm 001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.